Mandeep Chawla
Analyst · Bank of America
Thank you, Rob. And good morning everyone. Third quarter 2021 revenue came in at $1.47 billion at the midpoint of our guidance range. Revenue decreased 5% year-over-year and increased 3% sequentially. Our non Cisco revenues grew 6% year-over-year and grew 4% sequentially. We delivered non-IFRS operating margin of 4.2%, 20 basis points ahead of the midpoint of our guidance range driven by strong performance in both segments. Non-IFRS operating margin was up 30 basis points on both the year-over-year and sequential basis. Non-IFRS adjusted earnings per share were $0.35 towards the high end of our guidance range of $0.30 to $0.36, and up $0.03 year-over-year and up $0.05 sequentially. This marks our highest EPS in nearly five years. ATS revenue was up 12% compared to a year ago. In line with our expectations of a low double digit percentage year-over-year increase, sequentially ATS revenue was up 5%. Year-over-year, revenue growth in ATS was driven by a continuing recovery in our industrial business, another quarter of strong demand in capital equipment and solid performance in our HealthTech business. This was partly offset by softness in A&D specifically in our commercial aerospace business. CCS segment revenue was down 14% year-over-year and up 2% sequentially. The year over year decline was largely driven by the Cisco disengagement and demand volatility within certain programs in our enterprise end market. These declines were partly offset by strong demand from service provider customers, including in our HPS business, and an increase in demand from certain other programs in our enterprise end market. Our CCS revenues from customers other than Cisco increased by 2% year-over-year. Communications revenue declined 17% year-over-year greater than our expectation of a high single digit percentage decrease. The year-to-year decline was primarily driven by the Cisco disengagement and demand volatility in certain program, currently offset by strong demand from service provider customers. Sequentially, communications revenue was down 4%. Enterprise revenue in the quarter was down 7% year-over-year better than our expectation of a low 20 percentage decrease. Sequentially, enterprise revenue was up 16%. Our HPS business delivered revenue of $300 million, up 22% year-over-year, led by demand strength and new program ramps with service providers due to continued data center growth. Turning to segment margins, ATS delivered a segment margin of 4.3% in the third quarter up 60 basis points year-over-year and 20 basis points sequentially. This marks the sixth consecutive quarter of sequential ATS segment margin expansion. The year-over-year margin improvement was driven by profitable growth in capital equipment, which more than offset softness in aerospace and defense. CCS segment margin of 4.1% came in above our target range of 2% to 3%, up 10 basis points year-over-year and up 40 basis points sequentially. The year-over-year margin increase was driven by improvements, including continued growth in our HPS business. Moving on to some additional financial metrics. IFRS net earnings for the quarter were $35.2 million or $0.28 per share, compared to net earnings of $30.4 million or $0.24 per share in Q3, 2020 and net earnings of $26.3 million or $0.21 per share last quarter. Adjusted gross margin was 8.8%, up 70 basis points year-over-year and up 40 basis points sequentially. The year-over-year improvement was driven by growth in our HPS and capital equipment businesses and lower variable compensation partly offset by softness in A&D. Non-IFRS operating earnings were $61.3 million, up $1.2 million year-over-year and up $6.3 million sequentially. Our non-IFRS adjusted effective tax rate for the third quarter was 19%, an improvement of 1% year-over-year and sequentially. For the third quarter, non-IFRS adjusted net earnings were $43.4 million, compared to $40.9 million for the prior year period, and $37.9 million in the second quarter. Third quarter non-IFRS adjusted ROIC of 15.2% was flat year-over-year and up 1.5% sequentially. Moving on to working capital. Our inventory at the end of the quarter was $1.41 billion, up $201 million year-over-year and up $181 million sequentially, as we continue to support growth in our HPS business and increase inventory to support our customers in light of the current supply chain environment. To offset the working capital impacts of higher inventory, we continue to work with our customers on cash deposits when appropriate. Inventory turns in the third quarter were 4.1 turns, down from 4.7 turns in the prior year period and down from 4.4 turns last quarter. Capital expenditures for the third quarter were $16 million, or approximately 1% of revenue. Non-IFRS free cash flow was $27 million in the third quarter compared to $16 million in the prior year period, and $31 million last quarter. This is now our 11th consecutive quarter of delivering positive non-IFRS free cash flow, freeing our year-to-date total to $79 billion. Cash cycle days in third quarter were 72 days, up 11 days year-over-year and up one day sequentially. Cash cycle days increased on a year-over-year basis primarily due to higher inventory. Moving on to some additional key metrics. Our cash balance at the end of the third quarter was $477 million, up $26 million year-over-year and up $10 million sequentially. Combined with availability under our revolver, we continue to believe that our current liquidity of over $900 million is sufficient to meet our anticipated business needs. We ended the quarter with gross debt of $440 million unchanged from the previous quarter, leaving us with a net cash position of $37 million. Our third quarter gross debt to non-IFRS trailing 12-month adjusted EBITDA leverage ratio was 1.4 turns, flat sequentially, and an improvement of 0.2 turns from the same quarter last year. As we announced last month, following the anticipated closing of the PCI acquisition in November, we expect to add approximately $220 million of additional debt to our balance sheet through a new term loan. At September 30 2021, we were compliant with all financial covenants under our credit agreement. During the quarter, we repurchased approximately 2.1 million shares for cancellation at a cost of $17.2 million. Since commencing our NCIB program in November of 2020, we have repurchased a total of 4.4 million shares at a cost of $35.9 million. We ended the quarter with 124.7 million shares outstanding, a reduction of approximately 3% from the prior year period. We are pleased with our history of returning cash to shareholders while also investing in our business. While our long term capital allocation strategy remains unchanged, our focus in 2022 as a result of our acquisition of PCI will be to reduce our net debt. That being said, given what we see as a modest leverage balance, we believe, we also have the flexibility to opportunistically repurchase shares for cancellation when warranted. As such, we intend to commence a new NCIB program during the fourth quarter subjected to necessary approvals after our existing NCIB program expires in November. Now turning to our guidance for the fourth quarter of 2021. We would like to note that our Q4 guidance assumes a partial quarter of financial results from PCI. We are projecting fourth quarter revenue to be in the range of $1.425 billion to $1.575 billion. At the midpoint of this range, revenue would be up 2% sequentially, and up 8% year-over-year. This will be our first quarter with top line growth on a year-to-year basis since the third quarter of 2020. Fourth quarter non-IFRS adjusted earnings per share are expected to range from $0.35 to $0.41 per share. At the midpoint of our revenue and adjusted EPS guidance ranges, non-IFRS operating margin would be approximately 4.5%, an increase of 30 basis points sequentially, and up 90 basis points over the same period last year. This would represent Celestica's highest ever non-IFRS operating margin in our history as a publicly traded company. Non-IFRS adjusted SG&A expense for the fourth quarter is expected to be in the range of $62 million to $64 million. We anticipate our non-IFRS adjusted effective tax rate to be approximately 19%, excluding any impacts from taxable foreign exchange or unanticipated tax settlements. Turning to our end market outlook for the fourth quarter of 2021. In our ATS end market, we expect revenue to be up in the low 20s percentage range year-over-year, driven by continued demand strength in capital equipment, sustain momentum in industrial as well as a partial quarter of financial results from PCI. In CCS, we anticipate our communications end market revenue to be up in the low single digit percentage range year-over-year, driven by strong demand from service provider customers supported by our HPS offering and the beginning of Cisco's revenue lapsing from our comparatives. In our enterprise end market, we anticipate revenue to decrease in the low single digit percentage range year-over-year. I'll now turn the call back over to Rob for additional color on our end markets and overall business outlook.